4.7 Editorial Material

Mutant and Wild-type Ras: Co-conspirators in Cancer

Journal

CANCER DISCOVERY
Volume 3, Issue 1, Pages 24-26

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-12-0521

Keywords

-

Categories

Funding

  1. NATIONAL CANCER INSTITUTE [T32CA071341] Funding Source: NIH RePORTER
  2. NCI NIH HHS [T32 CA071341] Funding Source: Medline

Ask authors/readers for more resources

Although the functional interplay between mutant and wild-type Ras in driving tumor initiation and growth has been described, a clear picture of the precise ramifications and mechanisms of this association remains elusive, sometimes with conflicting conclusions. A report in this issue of Cancer Discovery tackles this question, which may have important implications for therapeutic strategies to block mutant Ras for cancer treatment. Cancer Discov; 3(1); 24-6. (C) 2012 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available